{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:25:22Z","timestamp":1773455122821,"version":"3.50.1"},"reference-count":48,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T00:00:00Z","timestamp":1288742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Therapeutics"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p> <jats:bold>Background:<\/jats:bold> Chronic kidney disease (CKD) is an increasingly health disease all around the world with a high burden of mortality and cardiovascular (CV) morbidity rate. Even when renal replacement therapy is reached, more than half patients die, mainly for CV causes due either to uremia\u2010related cardiovascular risk factors (such as anemia, hyperhomocysteinemia, mineral bone disease\u2013CKD with hyperparathyroidism, oxidative stress, hypoalbuminemia, chronic inflammation, prothrombotic factors) or to traditional ones (age, male gender, diabetes, obesity, hypertension, smoking, insulin levels, family history, dyslipidemia). Among the latter causes dyslipidemia represents one of the major, potentially correctable risk factor. <jats:bold>Methods and Results:<\/jats:bold> Statins have demonstrated to effectively and safely reduce cholesterol levels in CKD patients. Here we will examine the effects of statins on CV risk factors in CKD patients and particularly in patients on dialysis treatment, in the light of the unfavorable results of the large trials 4D and AURORA, recently published, underlining the role of malnutrition\/inflammation as confounding factor. Probably it will be that only with a real prevention, starting statins even in the early stages of CKD, as indicated by <jats:italic>post hoc<\/jats:italic> analysis of large trials, that we will reach results in reducing the mortality rate in CKD patients. In the meanwhile, all the other remediable CV risk factors have to be at the same time corrected.<\/jats:p>","DOI":"10.1111\/j.1755-5922.2010.00182.x","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T16:07:11Z","timestamp":1276531631000},"page":"361-368","source":"Crossref","is-referenced-by-count":17,"title":["Dyslipidemia in Chronic Kidney Disease: Are Statins Still Indicated in Reduction Cardiovascular Risk in Patients on Dialysis Treatment?"],"prefix":"10.1111","volume":"28","author":[{"given":"Roberto","family":"Scarpioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Melfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Cristinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60952-6"},{"issue":"42","key":"e_1_2_4_3_2","first-page":"S3","volume":"25","author":"Bellizzi V","year":"2008","journal-title":"G Ital Nefrol"},{"key":"e_1_2_4_4_2","first-page":"3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report","volume":"17","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043545"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810177"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.35"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000075925"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.suppl_1.40"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007101128"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063557"},{"key":"e_1_2_4_12_2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/089686080602600503","article-title":"Statins for treatment of dyslipidemia in chronic kidney disease","volume":"26","author":"Shurraw S","year":"2006","journal-title":"Perit Dial Int"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.6.1462"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm760"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.6.1011"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9820472"},{"key":"e_1_2_4_17_2","first-page":"46","article-title":"Therapeutic tools for dyslipidemia in peritoneal dialysis patients","volume":"22","author":"Scarpioni R","year":"2009","journal-title":"J Nephrol"},{"key":"e_1_2_4_18_2","first-page":"S90","article-title":"Atherosclerosis in uremia: Possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation","volume":"62","author":"Nishizawa Y","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00544-5"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00744.x"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"issue":"1","key":"e_1_2_4_23_2","first-page":"38","article-title":"The role of altered lipid metabolism in the progression of renal disease: Experimental evidence","volume":"17","author":"Keane WF","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000087576"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.07121.x"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006090976"},{"key":"e_1_2_4_27_2","unstructured":"ScarpioniR MichielettiE PavoneL et al.Atherosclerotic Renovascular Disease: Medical therapy plus renal artery stenting compared with medical therapy alone do not offer more chances in preventing cardio\u2010vascular or renal events. Preliminary results of a prospective multicenter and randomized trial. World Congress of Nephrology Milan (Italy) 22\u201324 May 2009: Abstract #952277. Available from:http:\/\/www.postersessiononline.com\/173580348_eu\/congresos\/WCN2009\/aula\/\u2010Mon_74_WCN2009.pdf. [Accessed 21 November 2009."},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1482084"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511163332001"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.04.070"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005070779"},{"key":"e_1_2_4_32_2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0025-6196(11)60763-5","article-title":"Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease","volume":"83","author":"Shepherd J","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.11.043"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39472.580984.AE"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.03.022"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13636-7"},{"key":"e_1_2_4_37_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006010012"},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-2-200607180-00009"},{"key":"e_1_2_4_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.517565"},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12948-0"},{"key":"e_1_2_4_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.11.018"},{"key":"e_1_2_4_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000081698.10331.83"},{"issue":"3","key":"e_1_2_4_43_2","first-page":"S1","article-title":"K(DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000144024"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.4.451"},{"key":"e_1_2_4_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050461"},{"key":"e_1_2_4_47_2","doi-asserted-by":"publisher","DOI":"10.1159\/000182627"},{"key":"e_1_2_4_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907845"},{"key":"e_1_2_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.323"}],"container-title":["Cardiovascular Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-5922.2010.00182.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-5922.2010.00182.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:26:53Z","timestamp":1698737213000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-5922.2010.00182.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,3]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1755-5922.2010.00182.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-5922.2010.00182.x","archive":["Portico"],"relation":{},"ISSN":["1755-5914","1755-5922"],"issn-type":[{"value":"1755-5914","type":"print"},{"value":"1755-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,3]]}}}